0001712762 2026-08-27 2026-08-27 0001712762 1 2026-08-27 2026-08-27 iso4217:USD pure shares S-3 S-3 EX-FILING FEES 0001712762 bioAffinity Technologies, Inc. N/A N/A S-3 bioAffinity Technologies, Inc. false Equity Common Stock, par value $0.007 per share true 1709334 5.29 9042376.86 0.0001381 1248.75 9042376.86 1248.75 0.00 0.00 1248.75 Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended (the "Securities Act"), based upon the average of the high and low prices of the registrant's common stock as reported on The Nasdaq Capital Market on August 25, 2026. Pursuant to Rule 416 under the Securities Act, the shares of common stock offered hereby also include an indeterminate number of additional shares of common stock as may from time to time become issuable by reason of stock splits, stock dividends, recapitalizations or other similar transactions. Represents the resale of (i) 564,136 Pre-Funded Warrant Shares issuable upon exercise of Pre-Funded Warrants, (ii) 564,136 Series A Warrant Shares issuable upon exercise of the Series A Warrants, (iii) 564,136 Series B Warrant Shares issuable upon exercise of the Series B Warrants, and (iv) 16,926 Placement Agent Warrant Shares issuable upon exercise of the Placement Agent Warrants.